These findings not only enhance our understanding of the molecular mechanisms underlying obesity but also highlight RAF1 as a promising target for therapeutic strategies aimed at mitigating metabolic diseases. Here, RAF1 is linked to obesity due to melanocortin 4 receptor deficiency.